[Neuroprotective treatment of chronic cerebrovascular insufficiency]

Insights

Cerebrolysin improved blood flow in patients with chronic brain ischemia by enhancing erythrocyte properties. This treatment positively impacts neurological and cognitive functions in these patients.

Area of Science:

  • Neurology
  • Hematology

Background:

  • Chronic brain ischemia (CBI) affects neurological and cognitive functions.
  • CBI is classified into stages I and II.
  • Effective treatments for CBI are crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of cerebrolysin in patients with chronic brain ischemia (CBI) stages I and II.
  • To investigate the effects of cerebrolysin on neurological, emotional, and cognitive status.
  • To assess cerebrolysin's impact on hemorheological parameters, including erythrocyte aggregation and deformity.

Main Methods:

  • A study involving 300 patients with CBI, divided into stage I (195 patients) and stage II (105 patients).
  • A control group of 45 patients did not receive cerebrolysin.
  • Assessment included neurological and emotional status, cognitive functions, and hemorheological indicators (platelet and erythrocyte aggregation, deformity, morpho-densitometric parameters).

Main Results:

  • Cerebrolysin administration led to improvements in neurological and emotional status.
  • Cognitive functions showed positive changes following cerebrolysin treatment.
  • The study identified enhanced morpho-densitometric characteristics of erythrocytes and improved hemorheological properties, crucial for capillary blood flow.

Conclusions:

  • Cerebrolysin demonstrates efficacy in treating chronic brain ischemia stages I and II.
  • The drug positively influences cognitive and neurological functions.
  • Additional mechanisms of cerebrolysin action involve improving erythrocyte deformability and hemorheological parameters, vital for microcirculation.
Abstract

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
31
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
25
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
8